Good healthcare has long been guided by strong ethics – this is nothing new and would not be a surprise to anyone reading this. When the success of medicine itself is directly related to moral ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...

An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy.

Prosecutors in the US are seeking the death penalty for Luigi Mangione, the man detained in connection with the assassination of UnitedHealth chief executive Brian Thompson, if convicted.

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

I don’t need another baby stroller. For the past three months, I’ve been inundated with pregnancy ads promoting prenatal vitamins, birthing classes, infant clothing, and baby toys. What these ...

MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its cash reserves as it ushers its lead drug for inflammatory diseases ...

While it sends some signals about the priorities of new FDA Commissioner Dr Martin Makary, the actual impact of the directive ...

GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...

An international agreement on pandemic preparedness is finally complete after three years of negotiation. The World Health ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

This new approach to lab space is emblematic of a broader trend in real estate: the conversion of under-utilised office space ...